Prosecution Insights
Last updated: May 29, 2026

Examiner: IANNUZO, NATALIE NMN

Tech Center 1600 • Art Units: 1653

This examiner grants 12% of resolved cases

Performance Statistics

12.1%
Allow Rate
-47.9% vs TC avg
91
Total Applications
+80.0%
Interview Lift
1197
Avg Prosecution Days
Based on 33 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
3.2%
§102 Novelty
79.5%
§103 Obviousness
1.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17429299 MATERIALS AND METHODS FOR THE PREPARATION OF BACTERIAL CAPSULAR POLYSACCHARIDES Final Rejection The Regents of the University of California
17995827 METHOD OF PRODUCING POLYHYDROXYALKANOATE COPOLYMER MIXTURE AND TRANSFORMED MICROORGANISM Non-Final OA KANEKA CORPORATION
18032456 COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR RELATED DISORDERS Non-Final OA The Regents of the University of Michigan
18042378 Composition For Treating or Preventing Clostridium Difficile Infection Non-Final OA Seoul National University R&DB Foundation
18329130 METHODS FOR DETECTING ZEROVALENT NANOPARTICLE-MEDIATED OXIDATIVE STRESS IN CYANOBACTERIA Non-Final OA Morgan State University
18025963 COLLAGEN WITH SELECTIVE CHARACTERISTICS, COLLAGEN PRODUCTS CONTAINING SAME AND METHODS FOR PRODUCING SAME Non-Final OA COLLAGEN MATRIX, INC.
17613898 GLUCONATE DEHYDRATASE ENZYMES AND RECOMBINANT CELLS Non-Final OA BP Corporation North America Inc.
18006800 IMPROVEMENTS TO WASH SOLUTIONS FOR ANION EXCHANGE CHROMATOGRAPHY IN A METHOD OF PURIFICATION OF RECOMBINANTLY-PRODUCED RSV PROTEINS Non-Final OA Pfizer Inc.
17912114 TREATMENT METHOD, PRODUCTION METHOD, AND HYDROXYAPATITE FILLER Final Rejection HOYA TECHNOSURGICAL CORPORATION
18703591 COMPOSITION FOR AMELIORATING HAIR LOSS COMPRISING BOTULINUM-DERIVED PEPTIDE Non-Final OA BPMED CO., LTD.
18259613 LOW LIPID CONTENT OAT PROTEIN COMPOSITION WITHOUT TRACES OF ORGANIC SOLVENT OR SURFACTANT Non-Final OA ROQUETTE FRERES
17777939 THERMOSTABLE PHYTASE VARIANTS Non-Final OA DUPONT NUTRITION BIOSCIENCES APS
17904690 METHODS FOR ENGINEERING AMINO ACID AMMONIA LYASE ENZYMES AND ENZYMES THEREBY OBTAINED Non-Final OA Trustees of Tufts College
17906498 PROTEIN CROSSLINKING METHOD Final Rejection Amano Enzyme Inc.
18008820 Engineered Bacterial Strain and Method of Use for One-Pot Vitamin C Synthesis Non-Final OA WiSys Technology Foundation, Inc.
18559825 IMPROVED METHODS AND CELLS FOR INCREASING ENZYME ACTIVITY AND PRODUCTION OF INSECT PHEROMONES Non-Final OA FMC AGRICUL TURAL SOLUTIONS A/S
18482386 METHOD AND COMPOSITION FOR THE TREATMENT OF CANCER Non-Final OA AntiCancer Inc.
17633930 COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMS Non-Final OA Vedanta Biosciences, Inc.
17795930 COMPOSITION COMPRISING CARTILAGE INGREDIENT FOR REGENERATION OF CARTILAGE AND PREPARATION METHOD THEREFOR Non-Final OA L&C BIO Co., Ltd.
18278937 NEUROTOXIN COMPOSITIONS FOR USE IN TREATING HEADACHE Non-Final OA AEON Biopharma Sub, Inc.
18083656 METHODS AND KITS FOR ASSAYING A LARGE FLUID VOLUME USING FLOW CYTOMETRY Final Rejection HACH COMPANY
18269869 HEPATOCELLULAR CARCINOMA TREATMENTS, PROPHYLACTIC THERAPIES, AND COMPOSITIONS FOR USE THEREWITH Non-Final OA REPAIR BIOTECHNOLOGIES, INC.
18035480 COMPOSITIONS AND METHODS FOR TREATING SOLID CANCER Non-Final OA EXOXEMIS, INC.
18020048 METHOD FOR PRODUCING PROTEIN COMPOSITIONS Non-Final OA HOFFMAN-LA ROCHE INC.
18249097 METHODS OF TREATING SKIN CANCERS Non-Final OA MEDIWOUND LTD.
18030291 LONG-ACTING DNASE Final Rejection Protalix Ltd.
18190151 AGAROSE-CELLULOSE NANOCOMPOSITE POROUS GEL MICROSPHERE, PREPARATION METHOD, AND APPLICATION Non-Final OA Hangzhou NeuroPeptide Biological Science and Technology Incorporation, Ltd. (NUPTEC)
18007134 COMPOSITIONS AND METHODS FOR TREATING BACTERIAL INFECTIONS Final Rejection MUCPHARM PTY LTD
18010511 TRANSFORMANT OF GENUS HYDROGENOPHILUS BACTERIUM CAPABLE OF PRODUCING ASPARTIC ACID AND METHIONINE Final Rejection UTILIZATION OF CARBON DIOXIDE INSTITUTE CO., LTD.
17797907 MODIFIED MICROORGANISM AND METHOD FOR THE IMPROVED PRODUCTION OF ECTOINE Final Rejection METABOLIC EXPLORER

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month